Business Wire - Alfacell Completes Non-Clinical Section of Rolling NDA for Lead
Posted on Monday, October 02 @ 07:00:00 CDT by admin
October 2, 2006 -- BLOOMFIELD, N.J. -- Alfacell Corporation (NASDAQ: ACEL) today announced that the company has completed the non-clinical section of the rolling submission ...
Click Here to read the entire article...
|
| |
|